Drug intelligence / Profile preview

ML-800

Development stage
Preclinical
Lead developer
Moffitt Cancer Center
Modality
Peptides
Administration
Intravenous
01

Overview

ML-800 is a melanocortin 1 receptor (MC1R)-targeted optical imaging probe developed for the detection and molecular imaging of melanoma. It consists of a high-affinity peptidomimetic ligand specific for MC1R conjugated to an infrared dye. MC1R is a G protein-coupled receptor that is significantly overexpressed in the majority of human melanoma metastases while maintaining low expression in normal skin and other vital organs, providing a high signal-to-noise ratio for imaging. In preclinical studies, ML-800 demonstrated a high binding affinity (Ki of 0.4 nM) and specific accumulation in MC1R-expressing tumors in mouse models. Developed by researchers at the Moffitt Cancer Center and the University of Arizona, ML-800 serves as a prototype for the targeted delivery of imaging contrast or therapeutic agents to melanoma metastases.

02

Targets

MC1R (Melanocortin Type 1 Receptor)

Beyond the preview

Go deeper on ML-800.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ML-800.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call